Preview

User

Not a user? Register with this site Forgot your password?

Medical Genetics

Advanced search
Fullscreen

For citations:

Usenko T.S., Basharova K.S., Bezrukova A.I., Nikolaev M.A., Miliukhina I.V., Baydakova G.V., Zakharova E.Y., Pchelina S.N. Selective inhibition of LRRK2 activity as an approach to the treatment of Parkinson's disease. Medical Genetics. 2022;21(12):26-29. (In Russ.) https://doi.org/10.25557/2073-7998.2022.12.26-29

Views PDF (Rus): 107


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7998 (Print)

115478, Moscow, Moskvorechiye street, 1. 
Tel.: +7(499) 612-80-25; 612-81-07;
e-mail: L_Tarlycheva@med-gen.ru

Processing of personal data
supported by NEICON (Elpub lab)